Insights

Late preterm infants, born between 34-36 weeks, face higher risks for health issues and readmission. Despite this, they are often treated as full-term, requiring better clinical awareness and management strategies.

Area of Science:

  • Neonatology
  • Perinatology
  • Pediatrics

Background:

  • Late preterm infants (34-36 weeks gestation) are physiologically immature with limited compensatory responses.
  • Despite increased risks, they are often managed as term infants, leading to potential underestimation of their needs.
  • The late preterm birth rate is increasing due to various maternal, fetal, or placental factors.

Purpose of the Study:

  • To review the etiology, immediate, and long-term outcomes of late preterm infants.
  • To highlight the increased morbidity risks associated with this population.
  • To emphasize the need for specialized care and research for late preterm infants.

Main Methods:

  • Review of existing literature on late preterm infants.
  • Analysis of data regarding birth rates, clinical management, and outcomes.
  • Synthesis of information on associated morbidities and healthcare resource impact.

Main Results:

  • Late preterm infants exhibit a 2-3 fold increased risk of morbidities including hypothermia, hypoglycemia, respiratory distress, and jaundice.
  • These infants have higher readmission rates post-discharge.
  • Current practices often overlook their unique vulnerabilities, managing them with protocols for term infants.

Conclusions:

  • Late preterm infants require specific attention due to significant risks of morbidity and mortality.
  • Clinical practices need to adapt to better address the needs of this vulnerable population.
  • Further research is essential to optimize the care and outcomes for late preterm infants.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
231
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
219
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252